To determine whether these tumors differed significantly in T cell infiltrate, tumor infiltrating cells were isolated from day 14 tumors in mice treated with anti-CD40L or left untreated, and the immune infiltrate evaluated by flow cytometry. The gene discussed is CD40LG; the disease is neoplasm.